BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33982907)

  • 1. Antifungal Prophylaxis After Lung Transplantation: Where Are We Now?
    De Mol W; Bos S; Beeckmans H; Lagrou K; Spriet I; Verleden GM; Vos R
    Transplantation; 2021 Dec; 105(12):2538-2545. PubMed ID: 33982907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is universal antifungal prophylaxis mandatory in lung transplant patients?
    Schaenman JM
    Curr Opin Infect Dis; 2013 Aug; 26(4):317-25. PubMed ID: 23743815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal Prophylaxis in Lung Transplant Recipients.
    Patel TS; Eschenauer GA; Stuckey LJ; Carver PL
    Transplantation; 2016 Sep; 100(9):1815-26. PubMed ID: 26950711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
    Cadena J; Levine DJ; Angel LF; Maxwell PR; Brady R; Sanchez JF; Michalek JE; Levine SM; Restrepo MI
    Am J Transplant; 2009 Sep; 9(9):2085-91. PubMed ID: 19645709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic antifungal agents used after lung transplantation.
    Marino E; Gallagher JC
    Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal prophylaxis in lung transplant recipients: A systematic review and meta-analysis.
    Pennington KM; Baqir M; Erwin PJ; Razonable RR; Murad MH; Kennedy CC
    Transpl Infect Dis; 2020 Aug; 22(4):e13333. PubMed ID: 32449237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifungal prophylaxis in the postoperative period of lung transplant surgery in Spain].
    Sacanell J; Rey T; López E; Vicente R; Ballesteros MA; Iranzo R; Robles JC; Restrepo MI; Rello J;
    Med Intensiva; 2013 Apr; 37(3):201-5. PubMed ID: 23260267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal Prophylaxis and Treatment Among Lung Transplant Recipients in Early Postoperative Stage: A Single-Center Study.
    Pióro A; Latos M; Urlik M; Stącel T; Gawęda M; Pandel A; Przybyłowski P; Knapik P; Ochman M
    Transplant Proc; 2022 May; 54(4):1104-1108. PubMed ID: 35437151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
    He SY; Makhzoumi ZH; Singer JP; Chin-Hong PV; Arron ST
    Transpl Infect Dis; 2015 Feb; 17(1):14-20. PubMed ID: 25620387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPICO 3.0. Antifungal prophylaxis in solid organ transplant recipients.
    Zaragoza R; Aguado JM; Ferrer R; Rodríguez AH; Maseda E; Llinares P; Grau S; Muñoz P; Fortún J; Bouzada M; Pozo JC; León R;
    Rev Iberoam Micol; 2016; 33(4):187-195. PubMed ID: 27067875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
    Linder KA; Kauffman CA; Patel TS; Fitzgerald LJ; Richards BJ; Miceli MH
    Transpl Infect Dis; 2021 Feb; 23(1):e13448. PubMed ID: 33448560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole prophylaxis in lung transplant recipients.
    Husain S; Paterson DL; Studer S; Pilewski J; Crespo M; Zaldonis D; Shutt K; Pakstis DL; Zeevi A; Johnson B; Kwak EJ; McCurry KR
    Am J Transplant; 2006 Dec; 6(12):3008-16. PubMed ID: 17062003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Inhaled Amphotericin B Lipid Complex as Antifungal Prophylaxis in Lung Transplant Recipients.
    Huggins JP; Pease R; Stanly K; Workman A; Reynolds J; Alexander BD
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0028322. PubMed ID: 35506698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal prophylaxis in lung transplant: A survey of United States' transplant centers.
    Pennington KM; Yost KJ; Escalante P; Razonable RR; Kennedy CC
    Clin Transplant; 2019 Jul; 33(7):e13630. PubMed ID: 31173402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted versus universal antifungal prophylaxis among liver transplant recipients.
    Eschenauer GA; Kwak EJ; Humar A; Potoski BA; Clarke LG; Shields RK; Abdel-Massih R; Silveira FP; Vergidis P; Clancy CJ; Nguyen MH
    Am J Transplant; 2015 Jan; 15(1):180-9. PubMed ID: 25359455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal prophylaxis in solid organ transplant recipients.
    Brizendine KD; Vishin S; Baddley JW
    Expert Rev Anti Infect Ther; 2011 May; 9(5):571-81. PubMed ID: 21609268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to reducing hepatotoxicity related to fungal prophylaxis in pediatric lung transplant recipients.
    Patz-Sobczak C; Young J; Bunton D; Kuklinski C; Estabrook M
    Pediatr Transplant; 2024 May; 28(3):e14740. PubMed ID: 38616325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
    Koo S; Kubiak DW; Issa NC; Dietzek A; Boukedes S; Camp PC; Goldberg HJ; Baden LR; Fuhlbrigge AL; Marty FM
    Transplantation; 2012 Aug; 94(3):281-6. PubMed ID: 22790447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.